Newport Medical Instruments, Inc. (Newport), a manufacturer of ventilators for the portable, home care and critical care markets, has been acquired by Covidien plc. for US$108 million.
Newport is a physician-led company, focused on the design and manufacture of dependable ventilators that are affordable for caregivers worldwide.
Covidien plc. is a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices. Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.
Oaklins' team in Los Angeles was engaged by the shareholders of Newport to pursue a sale of the business.
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.